Hikma Pharmaceuticals USA Inc: Alendronate Sodium Oral Solution, 70 Mg/75 Ml

Alendronate Sodium Oral Solution Recall Hikma Pharmaceuticals is recalling Alendronate Sodium Oral Solution (70 mg/75 mL) distributed nationwide because some bottles that were stored on their side were found to contain incorrect drug levels. The recall affects a limited number of bottles with NDC 0054-0282-59 distributed across all U.S. states and Washington, D.C.

Recalling firm
Hikma Pharmaceuticals USA INC
Product
Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose Bottles, Distr. by: Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922, NDC 0054-0282-59.
Reason
This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
Category
drug recall
Country
United States
Agency
U.S. Food and Drug Administration
Recall date
2026-04-07
Status
Ongoing
Areas affected
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
Distribution
US Nationwide.

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/d41dfbea-3a1d-4262-87a6-213d59e37912